These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9849960)

  • 1. Certain activating mutations within helix 6 of the human luteinizing hormone receptor may be explained by alterations that allow transmembrane regions to activate Gs.
    Abell AN; McCormick DJ; Segaloff DL
    Mol Endocrinol; 1998 Dec; 12(12):1857-69. PubMed ID: 9849960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty.
    Latronico AC; Abell AN; Arnhold IJ; Liu X; Lins TS; Brito VN; Billerbeck AE; Segaloff DL; Mendonca BB
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2435-40. PubMed ID: 9661624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: a novel constitutively activating mutation in the first transmembrane helix.
    Latronico AC; Shinozaki H; Guerra G; Pereira MA; Lemos Marini SH; Baptista MT; Arnhold IJ; Fanelli F; Mendonca BB; Segaloff DL
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4799-805. PubMed ID: 11134146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty.
    Laue L; Chan WY; Hsueh AJ; Kudo M; Hsu SY; Wu SM; Blomberg L; Cutler GB
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):1906-10. PubMed ID: 7892197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phe576 plays an important role in the secondary structure and intracellular signaling of the human luteinizing hormone/chorionic gonadotropin receptor.
    Yano K; Kohn LD; Saji M; Okuno A; Cutler GB
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2586-91. PubMed ID: 9253338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness.
    Shinozaki H; Fanelli F; Liu X; Jaquette J; Nakamura K; Segaloff DL
    Mol Endocrinol; 2001 Jun; 15(6):972-84. PubMed ID: 11376115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the direct involvement of transmembrane region 6 of the lutropin/choriogonadotropin receptor in activating Gs.
    Abell AN; Segaloff DL
    J Biol Chem; 1997 Jun; 272(23):14586-91. PubMed ID: 9169417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel luteinizing hormone receptor mutation in a patient with familial male-limited precocious puberty: effect of the size of a critical amino acid on receptor activity.
    Wu SM; Leschek EW; Brain C; Chan WY
    Mol Genet Metab; 1999 Jan; 66(1):68-73. PubMed ID: 9973550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A constitutively active somatic mutation of the human lutropin receptor found in Leydig cell tumors activates the same families of G proteins as germ line mutations associated with Leydig cell hyperplasia.
    Hirakawa T; Ascoli M
    Endocrinology; 2003 Sep; 144(9):3872-8. PubMed ID: 12933660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The secondary structure of peptides derived from the third intracellular loop of the serpentine type receptors and its interrelation with their biological activity].
    Shpakova EA; Skvortsova EA; Tarasenko II; Shpakov AO
    Tsitologiia; 2012; 54(2):119-29. PubMed ID: 22590924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of activating mutations of the human luteinizing hormone receptor in male-limited precocious puberty.
    Laue L; Wu SM; Kudo M; Hsueh AJ; Cutler GB; Jelly DH; Diamond FB; Chan WY
    Biochem Mol Med; 1996 Aug; 58(2):192-8. PubMed ID: 8812739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty.
    Yano K; Saji M; Hidaka A; Moriya N; Okuno A; Kohn LD; Cutler GB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1162-8. PubMed ID: 7714085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases.
    Yano K; Hidaka A; Saji M; Polymeropoulos MH; Okuno A; Kohn LD; Cutler GB
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1818-23. PubMed ID: 7527413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of the binding affinity of the luteinizing hormone/choriogonadotropin receptor by sodium ions is mediated by a highly conserved aspartate located in the second transmembrane domain of G protein-coupled receptors.
    Quintana J; Wang H; Ascoli M
    Mol Endocrinol; 1993 Jun; 7(6):767-75. PubMed ID: 8395653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization of Gs-coupled receptor signaling by constitutively active mutants of the human lutropin/choriogonadotropin receptor.
    Shinozaki H; Butnev V; Tao YX; Ang KL; Conti M; Segaloff DL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1194-204. PubMed ID: 12629106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The formation of a salt bridge between helices 3 and 6 is responsible for the constitutive activity and lack of hormone responsiveness of the naturally occurring L457R mutation of the human lutropin receptor.
    Zhang M; Mizrachi D; Fanelli F; Segaloff DL
    J Biol Chem; 2005 Jul; 280(28):26169-76. PubMed ID: 15908694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling.
    Alvarez CA; Narayan P; Huang J; Puett D
    Endocrinology; 1999 Apr; 140(4):1775-82. PubMed ID: 10098515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly conserved serine in the third transmembrane helix of the luteinizing hormone/human chorionic gonadotropin receptor regulates receptor activation.
    Munshi UM; Pogozheva ID; Menon KM
    Biochemistry; 2003 Apr; 42(13):3708-15. PubMed ID: 12667061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis within helix 6 of the human beta1-adrenergic receptor identifies Lysine324 as a residue involved in imparting the high-affinity binding state of agonists.
    Zeitoun O; Santos NM; Gardner LA; White SW; Bahouth SW
    Mol Pharmacol; 2006 Sep; 70(3):838-50. PubMed ID: 16760361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of G protein-coupled receptors as a result of selective substitution of a conserved leucine residue in transmembrane helix III.
    Tao YX; Abell AN; Liu X; Nakamura K; Segaloff DL
    Mol Endocrinol; 2000 Aug; 14(8):1272-82. PubMed ID: 10935550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.